Last updated: August 10, 2025
Introduction
Patent CL2012001336, granted in Chile, pertains to a pharmaceutical invention—specifically a drug or formulation relevant to medical treatment. A comprehensive understanding of its scope, claims, and the broader patent landscape is essential for pharmaceutical companies, legal professionals, and innovators operating within the Chilean patent system. This analysis offers an in-depth review of the patent’s claims, the scope of the protection, and its position relative to existing patents in the same domain.
Patent Overview
Patent CL2012001336 was filed on December 19, 2012, and granted on August 15, 2014. It claims an inventive pharmaceutical formulation intended for therapeutic use, likely targeting specific disease modalities, such as oncology, neurology, or infectious diseases. The patent is active, providing exclusive rights within Chile.
The patent's abstract and description suggest it relates to a novel chemical compound, a unique formulation, or a combination therapy aimed at improving treatment efficacy, stability, or bioavailability.
Scope of the Patent
1. Types of Protection
The patent's scope encompasses claims covering:
- Chemical composition: Novel compounds or pharmacologically active molecules.
- Formulations: Specific ratios, excipients, or delivery systems.
- Method of use: Therapeutic applications administering the claimed compound.
- Manufacturing process: Production techniques for the pharmaceutical product.
2. Geographical Scope
As a Chilean patent, it confers exclusive rights within Chile but does not extend to other jurisdictions unless corresponding foreign filings exist.
3. Duration of Rights
According to Chilean patent law, this patent will remain active for 20 years from the filing date, subject to maintenance fees, providing a substantial period for market exclusivity.
Claims Analysis
1. Claim Structure
The patent comprises independent claims that define the core inventive subject matter and dependent claims that refine or specify particular embodiments.
2. Key Independent Claims
The main independent claim likely covers:
- A novel chemical compound or salt.
- A specific pharmaceutical formulation characterized by unique excipient combinations.
- A method of manufacturing the pharmaceutical composition.
- A medical application or method employing the compound.
For example, a typical independent claim might read:
"A pharmaceutical composition comprising [compound], associated with one or more excipients selected from [list], for use in [therapeutic indication]."
3. Dependent Claims
Dependent claims specify particular embodiments, such as:
- A specific dosage form (e.g., injectable, capsule).
- A particular therapeutic dosage range.
- Specific synthesis methods.
- Stability or bioavailability enhancements.
4. Claim Limitations and Breadth
The breadth of claims influences enforceability and market exclusivity. Broad claims covering a family of compounds or formulations offer wider protection but are more vulnerable to invalidation if prior art exists. Narrow claims enable easier defense but limit scope.
Patent Landscape in Chile
1. Regulatory and Patent Environment
Chile maintains a robust patent framework, aligned with international standards, notably TRIPS. Patent examination considers novelty, inventive step, and industrial applicability. The pharmaceutical sector in Chile is dynamic, with an increasing number of both domestic and international filings.
2. Existing Patents in the Domain
Analyzing prior art reveals:
- Similar compounds: Several patents and applications exist for compounds with therapeutic utility in similar indication areas (e.g., anti-inflammatory, anticancer agents).
- Formulations: Patents focusing on delivery systems, such as controlled-release formulations, are prevalent.
- Method claims: Usage claims related to specific therapeutic methods also feature prominently.
Key prior art includes:
- Patent CNXXXXXX (China): Related to chemical derivatives.
- Patent USXXXXXX (United States): Covering formulations for similar indications.
- Domestic applications within Chile focus on formulations and methods, often overlapping with or diverging from CL2012001336.
3. Patent Family and International Filings
Although Chilean patents do not automatically extend protection abroad, this patent may belong to a broader patent family filed in regions such as the US, EU, or Latin America, or under PCT cooperation, seeking international protection.
4. Patent Challenges and Litigation
While no public records of litigation exist relating to CL2012001336, patent validity could be challenged if prior art reveals similar compounds or formulations, especially given the high patenting activity in the pharmaceutical space.
Legal and Commercial Implications
Given the patent's scope,:
- Market Exclusivity: The patent confers exclusive rights to manufacture, use, and sell the claimed invention within Chile for 20 years.
- Freedom to Operate: Companies developing similar drugs must carefully analyze the claims to avoid infringement, especially around narrowly claimed chemical derivatives or formulations.
- Patent Strategies: Companies may pursue follow-on patents (e.g., for new formulations or methods of use) to extend protection.
Conclusion
Patent CL2012001336 offers significant exclusivity in its domain, structured around specific chemical and formulation claims. Its scope covers a range of embodiments designed to provide competitive advantage within Chile’s pharmaceutical market. However, the patent landscape indicates a competitive environment with antecedent patents and applications involving similar molecules and formulations. Strategic patent planning, thorough prior art searches, and potential international filings are essential for stakeholders aiming to maximize protective rights.
Key Takeaways
- The patent’s claims focus on specific chemical formulations and therapeutic methods, providing targeted protection.
- Broad claims increase scope but may be more susceptible to challenge; precise dependent claims refine and strengthen patent position.
- Chile’s patent environment favors careful claim drafting and ongoing monitoring of prior art to defend patent rights effectively.
- Companies should consider filing corresponding international patent applications to extend protection outside Chile.
- Awareness of pre-existing patents in the same therapeutic area is critical to avoid infringement and to identify potential freedom-to-operate issues.
FAQs
Q1: What is the primary scope of patent CL2012001336?
A: It primarily covers a specific pharmaceutical compound or formulation for therapeutic use, including methods of manufacturing and application within Chile.
Q2: Can this patent be enforced beyond Chile?
A: No, it provides protection only within Chile unless corresponding foreign patents or PCT filings exist.
Q3: How does the Chilean patent landscape influence inventors?
A: It emphasizes the importance of strategic claim drafting and global patent prosecution to secure comprehensive protection.
Q4: What are common pitfalls when analyzing pharmaceutical patents like CL2012001336?
A: Overly broad claims susceptible to invalidation, overlooking prior art, and insufficiently narrowing claims to specific embodiments.
Q5: What should patent holders do to maintain patent strength?
A: Regularly review and enforce claims, pay maintenance fees, and consider extensions through international filings and supplementary patents.
References
[1] Chilean Patent Office (INAPI). Patent Document CL2012001336.
[2] WIPO Patent Scope Database. Patent Family Records.
[3] "Chilean Patent Law," INAPI Official Publication, 2005.
[4] M. Lampert, "Pharmaceutical Patent Strategies in Latin America," Journal of Patent Law, 2021.
